ARG1 and central nervous system cancer: When this analysis considered glioma patients according to their grade, ARG1 activity at pH 7.1 remained an independent significant predictor of all grades of disease and, interestingly, significantly discriminated HD from low-grade gliomas, thus indicating that it is an early biomarker of glioma disease (Table 3, cohort 3), with an accuracy of 72%.